-
Chordoma Disease Therapeutics Market To Witness Substantial Growth, 2025-2032 | Sanofi SA, Astellas Pharma Inc
11 Dec 2025 12:26 GMT
… Inc.
◘ Sanofi SA
◘ Astellas Pharma Inc.
◘ AstraZeneca plc
◘ … ◘ Varian Medical Systems Inc. Amura Holdings Ltd.
◘ Catena pharmaceuticals Inc.
… Pharmaceuticals Inc
◘ Medivir
◘ Verdict Media Limited
◘ Mylan N.V.
Segmentation Overview:
◘ By Drug …
-
Biocon to merge biologics unit; to acquire stake held by Serum, Mylan
06 Dec 2025 12:50 GMT
Biotechnology major Biocon on Saturday (December … the residual stake held by Mylan Inc (Viatris) for a total … world's most pressing healthcare needs,” Ms. Mazumdar-Shaw stated … for nearly 40% of global pharmaceutical revenues.
“As the only company …
-
Urinary Incontinence Therapeutics Market Set To Explode Opportunities, Future Scope 2025-2032 | Astellas Pharma, Pfizer
03 Dec 2025 12:48 GMT
… for urinary incontinence medications.
Rising Geriatric Population … to the World Health Organization (WHO), the … impacts demand for drug-based therapies.
… Pharmaceutical
Merck
Janssen
Endo Pharmaceuticals
Mylan
Reddy’s Laboratories
Sumitomo Pharma …
-
Infertility Drugs And Devices Market Set to Boom: USD 13.17 Billion by 2032 with 6.3% CAGR Growth | CMI
28 Nov 2025 12:48 GMT
… Ltd.
◘ Vivus Inc. Mylan Pharmaceuticals Inc.
◘ Ferring Pharmaceuticals
◘ Cipla Ltd
◘ Aspargo … product development.
➤ Infertility Drugs And Devices Research Methodology:
… including food and beverages, biotechnology, chemical and materials, defense …
-
Regulatory, patent barriers may hinder global access to new HIV prevention drug: activists
28 Nov 2025 14:17 GMT
… Hetero Labs, Emcure, and Mylan (Viatris), to produce and … a medicine has been approved by the drug regulatory … generic manufacturers producing active pharmaceutical ingredients (API) and … , which includes Health GAP (Global), the Health Justice Initiative ( …
-
Generic versions of breakthrough HIV drug Lenacapavir still not available in India, say treatment activists
27 Nov 2025 18:59 GMT
… issued by American drugmaker Gilead Sciences to generic drugmakers including three form … , besides Eva Pharma (Egypt), Ferozsons Laboratories Ltd (Pakistan) and Mylan (a subsidiary … medicines for the world,” said Fatima Hassan of South Africa’s Health …
-
Myeloproliferative Disorders Drugs Market is Forecasted to Reach a Value of US $11.51 Billion by 2029
25 Nov 2025 00:00 GMT
… as adopting precision medicine strategies, clinical assessments … The Myeloproliferative Disorders Drugs Market?
The prevalence … National Institute of Health, a healthcare research body based … known for its pharmaceutical and biotechnology expertise, disclosed …
-
Generic Drugs Market Size to Worth USD 898 Billion by 2035, at a CAGR of 5.75% | Research by Vantage Market Research
25 Nov 2025 11:48 GMT
… Pharma R&D, API Manufacturers & Digital Health Platforms: Generic drug … Drugs Market
Mylan N.V.
Abbott Laboratories
ALLERGAN
Teva Pharmaceutical … supportive care medications.
Respiratory: … intelligence across healthcare, biotechnology, and advanced …
-
Ethical Pharmaceuticals Market Projected to Reach $13.05 Billion with 13.2% CAGR by 2029
21 Nov 2025 09:30 GMT
… involve precise medicine, digitization of healthcare and remote care, precision drug delivery … cancer, and heart disease. Ethical pharmaceutical medicines are usually recommended for sustained …
• Eli Lilly and Company
• Mylan NV
• Pfizer Inc.
What Are …
-
Biotech Ingredient Industry Report: Competitive Landscape and Future Prospects
21 Nov 2025 10:00 GMT
… medicines. Generic medicines are drugs designed to imitate the properties of prior authorized medications. Biotech … Inc.
• Teva Pharmaceutical Industries Ltd.
• Mylan Inc.
• Boehringer … biotech solutions, cosmetic energetics, and organic health …
About
© 1995-2025